Details for Patent: 8,633,178
✉ Email this page to a colleague
Which drugs does patent 8,633,178 protect, and when does it expire?
Patent 8,633,178 protects BIJUVA and is included in one NDA.
This patent has one hundred and sixty-one patent family members in twenty-one countries.
Summary for Patent: 8,633,178
| Title: | Natural combination hormone replacement formulations and therapies |
| Abstract: | Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized progesterone without estradiol; micronized progesterone with partially solubilized progesterone; solubilized estradiol with micronized progesterone; solubilized estradiol with micronized progesterone in combination with partially solubilized progesterone; and solubilized estradiol with solubilized progesterone. |
| Inventor(s): | Bernick; Brian A. (Boca Raton, FL), Cacace; Janice Louise (Miami, FL), Persicaner; Peter H. R. (Boca Raton, FL), Irani; Neda (Palm Beach Garden, FL), Amadio; Julia M. (Boca Raton, FL) |
| Assignee: | TherapeuticsMD, Inc. (Boca Raton, FL) |
| Application Number: | 13/684,002 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,633,178 |
|
Patent Claim Types: see list of patent claims | Formulation; Dosage form; |
Drugs Protected by US Patent 8,633,178
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma | BIJUVA | estradiol; progesterone | CAPSULE;ORAL | 210132-002 | Dec 28, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Mayne Pharma | BIJUVA | estradiol; progesterone | CAPSULE;ORAL | 210132-001 | Oct 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,633,178
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2782584 | ⤷ Sign Up | 301153 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2782584 | ⤷ Sign Up | 2021C/558 | Belgium | ⤷ Sign Up |
| European Patent Office | 2782584 | ⤷ Sign Up | 122021000080 | Germany | ⤷ Sign Up |
| European Patent Office | 2782584 | ⤷ Sign Up | LUC00245 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2782584 | ⤷ Sign Up | 132021000000197 | Italy | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
